We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Image: Bigstock
Achaogen (AKAO) Shows Strength: Stock Moves 17.8% Higher
Achaogen, Inc. was a big mover last session, as its shares rose almost 18% on the day. The upside was driven by a rating upgrade of the company. This also led to far more shares changing hands than in a normal session. Yesterday’s rally continues the recent uptrend for the company, as the stock is now up nearly 66% in the past one-month time frame.
Over the last 30 days, the company witnessed two positive estimate revisions and the Zacks Consensus Estimate also moved higher, suggesting more solid trading ahead. So make sure to keep an eye on this stock going forward to see if yesterday’s jump can turn into more strength down the road.
Achaogen currently has a Zacks Rank #3 (Hold) while its Earnings ESP is positive.
ACHOGEN INC Price
ACHOGEN INC Price | ACHOGEN INC Quote
A better-ranked med-drugs stock is Juniper Pharmaceuticals, Inc. , sporting a Zacks Rank #1 (Strong Buy).
Is AKAO going up? Or down? Predict to see what others think: Up or Down
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>